Literature DB >> 22870458

Current Aspects of Pathogenesis in Sjögren's Syndrome.

Michael Voulgarelis1, Athanasios G Tzioufas.   

Abstract

Sjögren's syndrome is a chronic autoimmune process that primarily affects the exocrine glands and leads to their functional impairment. The exocrine gland involvement is characterized by a focal, mononuclear cell infiltrate which is accumulated around ducts and, in some patients, extends and replaces the secretory functional units. The mechanisms of this autoimmune 'exocrinopathy' are not fully understood. The immune attack that follows activation or apoptosis of glandular epithelial cells exposing autoantigens in genetically predisposed individuals may drive the immune-mediated tissue injury. Abnormalities related to the upregulation of type I interferon-regulated genes (interferon signature), abnormal expression of B-cell-activating factor (BAFF) and activation of the IL-23/TH17 pathway are among the immune mediators implicated in the pathogenesis of autoimmune lesions within the salivary glands. Such abnormalities demonstrate the complex interplay between innate and adaptive immunity that contributes to autoimmune 'exocrinopathy'.

Entities:  

Keywords:  Sjögren's syndrome; apoptosis; autoimmune exocrinopathy; cytokines; pathogenesis

Year:  2010        PMID: 22870458      PMCID: PMC3383491          DOI: 10.1177/1759720X10381431

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


  80 in total

1.  Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice.

Authors:  S-T Ju; W N Jarjour; R Sharma; L Zheng; X Guo; S M Fu
Journal:  J Autoimmun       Date:  2007-01-03       Impact factor: 7.094

2.  Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome.

Authors:  László Kovács; Erzsébet Fehér; Ibolya Bodnár; Ilona Marczinovits; György M Nagy; János Somos; Viktória Boda
Journal:  Clin Immunol       Date:  2008-05-27       Impact factor: 3.969

3.  Serological implications of germinal center-like structures in primary Sjögren's syndrome.

Authors:  Malin V Jonsson; Kathrine Skarstein; Roland Jonsson; Johan G Brun
Journal:  J Rheumatol       Date:  2007-09-01       Impact factor: 4.666

4.  Role of dendritic cells in Sjögren's syndrome.

Authors:  P Vogelsang; M V Jonsson; S T Dalvin; S Appel
Journal:  Scand J Immunol       Date:  2006-09       Impact factor: 3.487

5.  Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.

Authors:  Peter Szodoray; Philip Alex; Malin V Jonsson; Nicholas Knowlton; Igor Dozmorov; Britt Nakken; Nicolas Delaleu; Roland Jonsson; Michael Centola
Journal:  Clin Immunol       Date:  2005-08-26       Impact factor: 3.969

Review 6.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

7.  Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.

Authors:  Maria I Christodoulou; Efstathia K Kapsogeorgou; Niki M Moutsopoulos; Haralampos M Moutsopoulos
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

8.  Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

Authors:  Cuong Q Nguyen; Min H Hu; Yi Li; Carol Stewart; Ammon B Peck
Journal:  Arthritis Rheum       Date:  2008-03

9.  Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.

Authors:  M N Manoussakis; S Boiu; P Korkolopoulou; E K Kapsogeorgou; N Kavantzas; P Ziakas; E Patsouris; H M Moutsopoulos
Journal:  Arthritis Rheum       Date:  2007-12

10.  Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function.

Authors:  Umesh S Deshmukh; Seshagiri Rao Nandula; Pushpa-Rekha Thimmalapura; Yogesh M Scindia; Harini Bagavant
Journal:  J Oral Pathol Med       Date:  2009-01       Impact factor: 4.253

View more
  10 in total

1.  Reduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.

Authors:  Margherita Sisto; Loredana Lorusso; Giuseppe Ingravallo; Roberto Tamma; Beatrice Nico; Domenico Ribatti; Simona Ruggieri; Sabrina Lisi
Journal:  J Mol Histol       Date:  2018-01-04       Impact factor: 2.611

Review 2.  New treatments for inflammatory rheumatic disease.

Authors:  Carlo Selmi; Elena Generali; Marco Massarotti; Gerolamo Bianchi; Carlo A Sciré
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 3.  B-cell survival factors in autoimmune rheumatic disorders.

Authors:  Sandra A Morais; Andreia Vilas-Boas; David A Isenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

Review 4.  Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  BMC Med       Date:  2015-02-06       Impact factor: 8.775

5.  B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedure.

Authors:  Sebastian Costa; Sacha Schutz; Divi Cornec; Arnaud Uguen; Isabelle Quintin-Roué; Agnès Lesourd; Jean-Marie Berthelot; Eric Hachulla; Pierre-Yves Hatron; Vincent Goeb; Olivier Vittecoq; Jacques Olivier Pers; Pascale Marcorelles; Alain Saraux; Valérie Devauchelle-Pensec
Journal:  Arthritis Res Ther       Date:  2016-01-20       Impact factor: 5.156

Review 6.  The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction.

Authors:  Babak Baban; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-08-14       Impact factor: 6.543

7.  Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.

Authors:  Niharika Singh; Ian Chin; Paul Gabriel; Emily Blaum; Sharmila Masli
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

8.  Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.

Authors:  Saba Nayar; Joana Campos; Charlotte G Smith; Valentina Iannizzotto; David H Gardner; Serena Colafrancesco; Elena Pipi; Florian Kollert; Kelly J Hunter; Charlotte Brewer; Christopher Dominic Buckley; Simon J Bowman; Roberta Priori; Guido Valesini; Maria Juarez; William A Fahy; Benjamin A Fisher; Andrew Payne; Rodger A Allen; Francesca Barone
Journal:  Ann Rheum Dis       Date:  2018-11-24       Impact factor: 19.103

9.  Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome.

Authors:  Estelle Gerossier; Saba Nayar; Mark J Murphy; Marianne M Martinic; Francesca Barone; Sylvie Froidevaux; Charlotte G Smith; Celine Runser; Valentina Iannizzotto; Enrico Vezzali; Gabin Pierlot; Ulrich Mentzel
Journal:  Arthritis Res Ther       Date:  2021-11-29       Impact factor: 5.156

Review 10.  The role of inflammation in the development of epilepsy.

Authors:  Amna Rana; Alberto E Musto
Journal:  J Neuroinflammation       Date:  2018-05-15       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.